Medicenna Therapeutics is a clinical-stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs). Their mission is to become the leader in the development and commercialization of targeted ECs and Superkines for the treatment of a broad range of cancers and immune-mediated diseases.

Biotechnology

Medicenna Therapeutics

Fahar Merchant

Eamonn Peters, CPA, CA

Temi Adeyemo

Manjunatha Ankathatti Munegowda, DVM, MS, PhD, mMBA

Hardeep Kataria

Ambica Rampal

Aanchal Sharma, PhD

Martin Bexon

Rosemina Merchant

The executive team at Medicenna Therapeutics has experience in the finance and administration departments of various companies in the biotech industry. They also have a background in accounting from Wilfrid Laurier University.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Medicenna Therapeutics

Board of Directors

Leadership Team